{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:32:47Z","timestamp":1791113567317,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4723,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1523-1755.2003.00707.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:52:16Z","timestamp":1047462736000},"page":"43-52","source":"Crossref","is-referenced-by-count":120,"title":["Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity"],"prefix":"10.1016","volume":"63","author":[{"given":"Iris","family":"Feria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Pichardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romeo","family":"Garc\u00eda-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"L\u00f3pez-Casillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma A.","family":"Bobadilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1681\/ASN.V12162","article-title":"Cellular and molecular mechanisms of cyclosporin nephrotoxicity","volume":"1","author":"Kopp","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ki.1990.139","article-title":"Role of endothelin in cyclosporine-induced glomerular dysfunction","volume":"37","author":"Kon","year":"1990","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0020","first-page":"76","article-title":"Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat","volume":"1","author":"Perico","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0025","first-page":"1242","article-title":"Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces cyclosporine nephrotoxicity in the rat","volume":"19","author":"Thomson","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0030","first-page":"F581","article-title":"Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A","volume":"251","author":"Perico","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0035","first-page":"F595","article-title":"Cyclosporin A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine","volume":"275","author":"Zhong","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1523-1755.1998.00835.x","article-title":"Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis","volume":"53","author":"Thomas","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1046\/j.1523-1755.2000.00999.x","article-title":"Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells","volume":"57","author":"Amore","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ki.1997.380","article-title":"Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy","volume":"52","author":"Shihab","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0055","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1046\/j.1523-1755.2000.00273.x","article-title":"Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity","volume":"58","author":"Shihab","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0060","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/00007890-199912150-00019","article-title":"Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow","volume":"68","author":"Vieira","year":"1999","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ki.1995.312","article-title":"Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity","volume":"48","author":"Young","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 68","key":"10.1046\/j.1523-1755.2003.00707.x_bb0070","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1046\/j.1523-1755.1998.06808.x","article-title":"Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases","volume":"54","author":"Ortiz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0075","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1523-1755.2001.060003847.x","article-title":"Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney","volume":"60","author":"Yang","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0080","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041552-200101000-00016","article-title":"Aldosterone in renal disease","volume":"10","author":"Hostetter","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3181\/00379727-92-22601","article-title":"Turbidimetric determination of proteins with sulfoasalicylic and tricholoroacetic acid","volume":"92","author":"Henry","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0120","series-title":"Molecular Cloning. A Laboratory Manual","first-page":"7","author":"Sambrook","year":"1989"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0125","first-page":"F791","article-title":"Role of NO in cyclosporin nephrotoxicity: Effects of chronic NO inhibition and NO synthases gene expression","volume":"274","author":"Bobadilla","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0130","first-page":"55","article-title":"Semi-quantitative PCR: A tool to study low abundance messages in the kidney","volume":"28","author":"Bobadilla","year":"1997","journal-title":"Arch Med Res"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0135","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0140","first-page":"F679","article-title":"Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease","volume":"262","author":"Rocco","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0145","doi-asserted-by":"crossref","first-page":"F727","DOI":"10.1152\/ajprenal.2001.280.4.F727","article-title":"Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor","volume":"280","author":"Kang","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0150","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00007890-199911270-00025","article-title":"Pentosan polysulfate treatment reduces cyclosporine-induced nephropathy in salt-depleted rats","volume":"68","author":"Schwedler","year":"1999","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0272-6386(12)80336-2","article-title":"Potential physiologic roles for epidermal growth factor in the kidney","volume":"17","author":"Harris","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00007890-199507150-00017","article-title":"Combined antagonism of endothelin A\/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats","volume":"60","author":"Kon","year":"1995","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0165","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/00007890-199711150-00002","article-title":"Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity","volume":"64","author":"Andoh","year":"1997","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000020504","article-title":"Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats","volume":"6","author":"Yang","year":"1998","journal-title":"Exp Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0175","first-page":"F464","article-title":"Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin","volume":"277","author":"Bobadilla","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0180","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1172\/JCI116777","article-title":"Arginine feeding modifies cyclosporine nephrotoxicity in rats","volume":"92","author":"De Nicola","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ki.1995.213","article-title":"A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine","volume":"47","author":"Amore","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0190","first-page":"501","article-title":"Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats","volume":"17","author":"Iacona","year":"1991","journal-title":"Drugs Exp Clin Res"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0200","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: A mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0205","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0210","doi-asserted-by":"crossref","first-page":"E1122","DOI":"10.1152\/ajpendo.2001.281.6.E1122","article-title":"Nontraditional aspects of aldosterone physiology","volume":"281","author":"Ngarmukos","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.19.3.270","article-title":"Aldosterone reduces baroreceptor discharge in the dog","volume":"19","author":"Wang","year":"1992","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0220","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.HYP.21.6.929","article-title":"Vasodilation to acetylcholine in primary and secondary forms of human hypertension","volume":"21","author":"Taddei","year":"1993","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0225","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0022-4731(89)90250-1","article-title":"Mineralocorticoid-induced increase in beta-adrenergic receptors of cultured rat arterial smooth muscle cells","volume":"33","author":"Jazayeri","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0230","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1139\/y85-250","article-title":"Effect of aldosterone on vascular angiotensin II receptors in the rat","volume":"63","author":"Schiffrin","year":"1985","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1046\/j.1523-1755.2003.00707.x_bb0235","first-page":"H608","article-title":"Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats","volume":"246","author":"Schiffrin","year":"1984","journal-title":"Am J Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381548843X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381548843X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T04:41:14Z","timestamp":1622868074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381548843X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S008525381548843X"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00707.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}